Farmax
Farmax, officially known as Farmax S.A., is a prominent player in the pharmaceutical industry, headquartered in Spain (ES). Established in 1999, the company has made significant strides in the development and distribution of high-quality generic medications, primarily focusing on therapeutic areas such as neurology and psychiatry. With a strong operational presence across Europe, Farmax is recognised for its commitment to innovation and quality, offering a diverse portfolio of products that cater to the evolving needs of healthcare professionals and patients alike. Their unique formulations and rigorous quality control processes set them apart in a competitive market. Farmax has achieved notable milestones, including strategic partnerships and expansions that have solidified its market position, making it a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does Farmax's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Farmax's score of 5 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Farmax's reported carbon emissions
In 2022, Farmax reported total carbon emissions of approximately 3,138,350 kg CO2e, comprising 1,776,150 kg CO2e from Scope 1 and 1,461,700 kg CO2e from Scope 2. This marked a significant increase from 2021, where emissions were about 1,138,000 kg CO2e (389,000 kg CO2e from Scope 1 and 749,000 kg CO2e from Scope 2). In 2020, the company emitted approximately 2,598,000 kg CO2e, with 658,000 kg CO2e from Scope 1 and 2,038,000 kg CO2e from Scope 2. Despite these figures, Farmax has not disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of defined climate commitments or science-based targets suggests a need for enhanced transparency and action in their climate strategy. As the industry increasingly prioritises sustainability, Farmax's future commitments will be crucial in aligning with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 658,000 | 000,000 | 0,000,000 |
| Scope 2 | 2,038,000 | 000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Farmax is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
